Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma.

CONCLUSIONS: In a large cohort of patients with stage I MOC, receiving chemotherapy was not associated with a survival benefit.
PMID: 31155308 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - May 29, 2019 Category: Cancer & Oncology Authors: Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA Tags: Gynecol Oncol Source Type: research